These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6816316)

  • 1. Chemoendocrine therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Breast Cancer Res Treat; 1981; 1(2):105-9. PubMed ID: 6816316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
    Iino Y; Yamazaki K; Ishikawa H; Endo K; Arai T; Ogawa T; Hoshino K; Ishida T; Yokoe T; Takahashi T
    Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.
    von Angerer E; Prekajac J; Berger M
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):531-7. PubMed ID: 3924626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H; Morimoto T; Monden A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of hormone and cytotoxic agents in advanced breast cancer.
    Kiang DT; Frenning DH; Gay J; Goldman AI; Kennedy BJ
    Cancer; 1981 Feb; 47(3):452-6. PubMed ID: 7013960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y; Schneider MR; Michna H
    J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new drugs for endocrine tumour chemotherapy.
    von Angerer E
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
    Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of chemotherapy and hormonal therapy in advanced breast cancer.
    Kiang DT; Gay J; Goldman A; Kennedy BJ
    N Engl J Med; 1985 Nov; 313(20):1241-6. PubMed ID: 3903501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.
    Kranzfelder G; Hartmann RW; von Angerer E; Schönenberger H; Bogden AE
    J Cancer Res Clin Oncol; 1982; 103(2):165-80. PubMed ID: 6284766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
    Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Collins J; Lindtner J; Thürlimann B; Fey MF; Murray E; Forbes JF; Coates AS; Goldhirsch A;
    Breast Cancer Res Treat; 2009 Aug; 116(3):491-500. PubMed ID: 18953651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor-inhibiting effect of diethylstilbestrol-3,4-oxide.
    Schneider MR; Kranzfelder G; von Angerer E; Schönenberger H; Metzler M; Michel RT; Fortmeyer HP; Ruckdeschel G
    J Cancer Res Clin Oncol; 1981; 100(3):247-54. PubMed ID: 6792206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial.
    Glick JH; Creech RH; Torri S; Holroyde C; Brodovsky H; Catalano RB; Varano M
    Cancer; 1980 Feb; 45(4):735-41. PubMed ID: 6986969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and cytostatic treatment of experimental mammary cancer.
    Fiebig HH; Schmähl D
    Recent Results Cancer Res; 1980; 71():80-95. PubMed ID: 6768114
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer adjuvants: results of a DUR (drug utilization research) study].
    Nuzzo A
    Suppl Tumori; 2004; 3(4):S86-7. PubMed ID: 15206223
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer].
    Garin AM; Dmitrieva NV; Vyshinskaia GV; Lichintser MR
    Vopr Onkol; 1987; 33(11):13-7. PubMed ID: 3686916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.